Emglif LM XR 2.5+12.5+1000mg
Linagliptin + Empagliflozin + Metformin 2.5mg + 12.5mg + 1000mg, tablet
Manufactured by Genix Pharma. Distributed in Iraq by Jaddaf Company.
2.5mg + 12.5mg + 1000mg
About Emglif LM XR 2.5+12.5+1000mg
Triple combination therapy for type 2 diabetes, integrating a DPP-4 inhibitor, SGLT2 inhibitor, and Metformin for comprehensive glycemic control.
This page is for healthcare professionals and trade customers. Use this medicine only as directed by a doctor or pharmacist, and always read the approved leaflet in the pack.
Product details
- Active ingredient
- Linagliptin + Empagliflozin + Metformin
- Strength
- 2.5mg + 12.5mg + 1000mg
- Dosage form
- Tablet
- Pack size
- 30's
- Manufacturer
- Genix Pharma
- Registration status in Iraq
- Registered
